Duffy phenotype does not influence the clinical severity of sickle cell disease

Clin Immunol. 2000 Sep;96(3):264-8. doi: 10.1006/clim.2000.4884.

Abstract

The red blood cell Duffy antigen receptor for chemokines serves as a sink for the clearance of chemokines such as interleukin-8 (IL-8) from the circulation. We analyzed the impact of the Duffy phenotype on sickle cell disease (SCD) severity and serum IL-8 levels in 15 Duffy-positive and 36 Duffy-negative sickle cell patients. There was no difference in clinical severity between Duffy-positive and Duffy-negative sickle cell patients. In asymptomatic sickle cell patients the upward deviation of mean serum IL-8 levels was significantly greater in Duffy-negatives (n = 20) than in Duffy-positives (n = 8) (P = 0.011). However, during a vasoocclusive episode, serum IL-8 levels were similar between Duffy-negatives (n = 11) and Duffy-positives (n = 3). Although the Duffy phenotype seems to influence steady-state serum IL-8 levels, it does not seem to have an effect on SCD severity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Arterial Occlusive Diseases / blood
  • Arterial Occlusive Diseases / genetics
  • Duffy Blood-Group System / genetics*
  • Female
  • Hematocrit
  • Hemoglobins / metabolism
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Phenotype
  • Platelet Count
  • Severity of Illness Index
  • Sickle Cell Trait / complications
  • Sickle Cell Trait / genetics*

Substances

  • Duffy Blood-Group System
  • Hemoglobins